Cargando…
Chorioallantoic Membrane Tumor Model for Evaluating Oncolytic Viruses
Oncolytic viruses are promising anticancer agents; however, regarding their clinical efficacy, there is still significant scope for improvement. Preclinical in vivo evaluation of oncolytic viruses is mainly based on syngeneic or xenograft tumor models in mice, which is labor-intensive and time-consu...
Autores principales: | Krutzke, Lea, Allmendinger, Ellen, Hirt, Katja, Kochanek, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585625/ https://www.ncbi.nlm.nih.gov/pubmed/32552215 http://dx.doi.org/10.1089/hum.2020.045 |
Ejemplares similares
-
Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer
por: Reale, Alberto, et al.
Publicado: (2023) -
EGFR-Binding Peptides: From Computational Design towards Tumor-Targeting of Adeno-Associated Virus Capsids
por: Feiner, Rebecca C., et al.
Publicado: (2020) -
Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
por: Krutzke, Lea, et al.
Publicado: (2022) -
Evaluation of Human Mesenchymal Stromal Cells as Carriers for the Delivery of Oncolytic HAdV-5 to Head and Neck Squamous Cell Carcinomas
por: Nilson, Robin, et al.
Publicado: (2023) -
In Vivo Vasospasm Induction by Ultrasound Application in the Chicken Chorioallantoic Membrane Model
por: Döring, Katja, et al.
Publicado: (2022)